Physician profile
Barbara S Yates
NPI 1164616686
$1,876.77
in general payments reported to CMS, 2019-2025
11 companies · $570 in 2025
The $570 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.09 · 2021: $240 · 2022: $196 · 2023: $154 · 2024: $657 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $650.19 | 2024-2025 | Tepezza, Uplizna |
| Alcon Vision LLC | $378.98 | 2023-2025 | Clareon, Centurion |
| Viiv Healthcare Company | $185.22 | 2022-2024 | Dovato |
| Ocular Therapeutix, INC. | $135.98 | 2021 | |
| Genentech USA, INC. | $119.89 | 2022 | |
| Horizon Therapeutics Plc | $109.82 | 2020-2022 | |
| Acelrx Pharmaceuticals, INC. | $103.92 | 2021 | |
| New World Medical,INC. | $79.55 | 2025 | Streamline, Clearpath, Via360 |
| Catalyst Pharmaceuticals, INC. | $62.47 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $27.50 | 2025 | Iolmaster 700 |
| Johnson & Johnson Surgical Vision, INC. | $23.25 | 2024 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Yates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.